|
US2020123188A1
|
|
Synthetic molecule constructs
|
|
US2019195759A1
|
|
Biocompatible method of functionalising substrates with inert surfaces
|
|
US2017218027A1
|
|
Functional lipid constructs
|
|
AU2013201431A1
|
|
Functional lipid constructs
|
|
NZ591514A
|
|
Assay method
|
|
NZ577689A
|
|
Method of diagnosing Treponema palladium infection with lipid linked antigen
|
|
NZ571727A
|
|
Neutralizing antibodies associated with ABO blood groups using antigen-lipid constructs
|
|
NZ584559A
|
|
Functional lipid constructs
|
|
CN101918841A
|
|
Peptide-lipid constructs and their use in diagnostic and therapeutic applications
|
|
NZ584558A
|
|
Peptide-lipid constructs and their use in diagnostic and therapeutic applications
|
|
NZ582229A
|
|
Carbohydrate-lipid constructs and their use in preventing or treating viral infection
|
|
WO2008133534A2
|
|
Carbohydrate-lipid constructs and their use in preventing or treating viral infection
|
|
EP2069460A2
|
|
Fluorescent cell markers
|
|
CN101282985A
|
|
Cell surface coating with hyaluronic acid oligomer derivative
|
|
NZ577912A
|
|
Fluorescent cell markers
|
|
NZ542568A
|
|
Method of localising hyaluronic acid to the surface of a cell
|
|
CA2560781A1
|
|
Synthetic membrane anchors
|
|
AU2004212104A1
|
|
Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents
|
